In its first-quarter 2026 investor letter, Jensen Quality Mid Cap Fund highlighted Labcorp Holdings Inc. (NYSE:LH) as one of the leading performance contributors.
Labcorp Holdings Inc. (NYSE:LH) is a leading laboratory services company that operates through the Diagnostics Laboratories and Biopharma Laboratory Services segments
The one-month return of Labcorp Holdings Inc. (NYSE:LH) was -5.13%, and its shares gained 2.03% of their value over the last 52 weeks. On May 11, 2026, Labcorp Holdings Inc. (NYSE:LH) stock closed at $255.08 per share with a market capitalization of $20.92 billion. Jensen Quality Mid Cap Fund stated the following regarding Labcorp Holdings Inc. (NYSE:LH) in its Q1 2026 investor letter: “Other notable companies that contributed positively to Portfolio performance during the quarter were Labcorp Holdings Inc. (NYSE:LH) and The Toro Company (TTC).
Along with Quest Diagnostics Incorporated, LH is one of the largest providers of diagnostic testing services in the U.S. LH performs over 6,500 different tests, ranging from routine preventative screenings, such as blood and urine tests, to specialized genomic profiling. The company is one of the Portfolio’s largest holdings due to their strong market position, economies of scale versus smaller competitors, and the stability of demand for its services.